Early De-Risking and Optimization

Yvette Stallwood, Ph.D.

Yvette Stallwood completed her PhD at the University of Birmingham (UK) and has a background in Virology, Cell and Molecular Biology. She joined Lonza in 2007, initially leading the cell and molecular biology expression group in the Early Development Services department and is currently Head of Early Development Services and Head of Lonza’s Cambridge site. The Early Development Services team is focused on the development and provision of services to support the development of new biotherapeutic proteins and vaccines with a particular focus on immunogenicity, manufacturability and protein expression.

Content by this expert

Recently published by Yvette

eBook

The Importance of Assessing and Mitigating Immunogenicity Potential

While the reasons for clinical failure vary, a large portion is due to issues with safety and...

Webinar (on-demand)

Maximize your chances of success: Avoid and mitigate risk of failure when developing...

Join Yvette Stallwood, PhD our Head of Applied Protein Services in this webinar about advancing your...